Finance

Beta
Lists
VVY:AMS
Vivoryon Therapeutics NV
€1.24
+2.48%
(+0.030) 1D
Jun 5, 5:35:13 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VVY...
Open
€1.20
High
€1.24
Low
€1.17
Mkt. cap
36.60M
Avg. vol.
60.25K
Volume
52.02K
52-wk high
€1.84
52-wk low
€1.10
EPS
-€0.30
Shares outstanding
26.07M
No. of employees
13
Open
€1.20
High
€1.24
Low
€1.17
Mkt. cap
36.60M
Avg. vol.
60.25K
Volume
52.02K
52-wk high
€1.84
52-wk low
€1.10
EPS
-€0.30
Shares outstanding
26.07M
No. of employees
13
News stories
From sources across the web
About Vivoryon Therapeutics NV
CEO-
Employees13
Founded1997
Headquarters-
SectorBiotechnology
Websitevivoryon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.38M
1.38M
806.50K
806.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.38M
1.38M
1.02M
1.02M
Operating expense
2.76M
2.76M
1.69M
1.69M
Total operating expenses
2.76M
2.76M
1.69M
1.69M
Operating income
-2.76M
-2.76M
-1.69M
-1.69M
Other non operating income
-
-
-
-
EBT including unusual items
-2.74M
-2.74M
-1.69M
-1.69M
EBT excluding unusual items
-2.74M
-2.74M
-1.69M
-1.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-132.50K
-132.50K
Net income
-2.74M
-2.74M
-1.69M
-1.69M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
35.00K
35.00K
15.50K
15.50K
Interest expense
-11.50K
-11.50K
-11.00K
-11.00K
Net interest expenses
23.50K
23.50K
4.50K
4.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.74M
-2.74M
-1.67M
-1.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer